AK

Avneet Kaur

Active Director Director DIN 06738656
DIN 06738656 First appointment Dec 2013 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2013
Shareholding value •••• Premium profile

About Avneet Kaur

Data last updated:

Avneet Kaur is a Director at Headway Pharma Private Limited (since 2013). The company operates in Trading. Headway Pharma Private Limited reported revenue of ₹74.2 Lakh (FY 2025).

DIN 06738656
Primary Designation Director
Industry Trading
First Appointment 20 Dec 2013
Oldest Company Age 12 yrs
Largest company Headway Pharma Private Limited · ₹74.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Headway Pharma Private Limited U85190UR2013PTC000967
Director20 Dec 20132013₹74.2 Lakh (FY 2025)Active

Board colleagues of Avneet Kaur

NameDINCompanyDesignation
Ashish Arora06601656Headway Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Headway Pharma Private Limited
Premium access

Shareholding and investment profile for Avneet Kaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avneet Kaur

Avneet Kaur currently holds 1 directorship: Headway Pharma Private Limited (Director, since 20 Dec 2013, revenue ₹74.2 Lakh (FY 2025)).

Avneet Kaur was first appointed on 20 Dec 2013 as Director at Headway Pharma Private Limited.

The current boards of Avneet Kaur's companies include Ashish Arora (Headway Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available